Bastide Le Confort Médical (BLC) Q3 2026 TU earnings summary

Executive summary

• Nine-month revenue reached €391.9 million, up 7.0% year-over-year, with organic growth at 7.2%.

• Home healthcare services grew 8.5%, while Homecare rose 5.2%, despite a one-off impact from the VPH reform in Q3.

• The VPH reform temporarily slowed Homecare growth in Q3, but momentum is expected to recover in Q4.

Financial highlights

• Q3 2025-2026 revenue was €131.5 million, up 5.0% year-over-year.

• Homecare revenue for nine months was €150.9 million, up 5.2%.

• Healthcare institutions revenue rose 11.3% to €70.2 million, driven by strong contract performance.

• Respiratory business revenue increased 10.2% organically to €130.9 million.

• Nutrition-Perfusion-Diabetes-Stomatherapy revenue reached €110.1 million, up 6.5%.

Outlook and guidance

• Revenue target for 2025-2026 set at a minimum of €510 million, with a stable operating margin around 9.0%.

• Store activity expected to improve in Q4 as the VPH reform impact subsides.

• Continued structural growth anticipated in home healthcare services.